XML 30 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION
 12 Months Ended
Dec. 31, 2017
SEGMENT INFORMATION  
SEGMENT INFORMATION

18.       SEGMENT INFORMATION

The Company's operations are in one business segment: the development, manufacture and marketing of medical devices. Each of the Company's product lines has similar characteristics, customers, distribution and marketing strategies, and are subject to similar regulatory requirements. Substantially all of the Company's long-lived assets are located in Canada. The Company carries on business in Canada and the United States. The Company earns revenue from sales to customers in the following geographic locations:

                                                                                                                                                                                    

 

 

 

For the years ended December 31,

 

 

 

 

2017

 

2016

 

2015

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

United States

 

$
466,471

 

$
4,832,977

 

$
4,932,791

 

 

Europe

 

 
4,393,303

 

 
4,251,260

 

 
4,831,678

 

 

Rest of the World

 

 
529,240

 

 
428,559

 

 
165,471

 

 

 

 

 

 

 

 

 

 

 

 

 

$
5,389,014

 

$
9,512,796

 

$
9,929,940

 

 

 

 

 

 

 

 

 

 

 

Sales to the Company's four largest customers accounted for approximately 57%, 9%, 6%, and 6% of the Company's sales for the year ended December 31, 2017. Sales to the Company's three largest customers accounted for approximately 36%, 32%, and 15% of the Company's sales for the year ended December 31, 2016. Sales to the Company's four largest customers accounted for approximately 30%, 29%,18% and 10% of the Company's sales for the year ended December 31, 2015.